Azimuth Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $16M | Buy |
66,094
+140
| +0.2% | +$33.9K | 0.69% | 42 |
|
|
2021
Q4 | $17.2M | Sell |
65,954
-3,210
| -5% | -$833K | 0.69% | 47 |
|
|
2021
Q3 | $18.2M | Sell |
69,164
-4,035
| -6% | -$1.1M | 0.78% | 36 |
|
|
2021
Q2 | $18M | Sell |
73,199
-1,975
| -3% | -$415K | 0.78% | 36 |
|
|
2021
Q1 | $14.6M | Sell |
75,174
-40
| -0.1% | -$8.02K | 0.69% | 42 |
|
|
2020
Q4 | $16M | Sell |
75,214
-1,425
| -2% | -$284K | 0.79% | 35 |
|
|
2020
Q3 | $13.1M | Buy |
76,639
+740
| +1% | +$137K | 0.77% | 44 |
|
|
2020
Q2 | $14.6M | Sell |
75,899
-4,550
| -6% | -$744K | 0.93% | 30 |
|
|
2020
Q1 | $11.8M | Sell |
80,449
-5,795
| -7% | -$923K | 0.89% | 31 |
|
|
2019
Q4 | $13.4M | Sell |
86,244
-3,045
| -3% | -$439K | 0.81% | 35 |
|
|
2019
Q3 | $12.1M | Sell |
89,289
-4,410
| -5% | -$578K | 0.79% | 37 |
|
|
2019
Q2 | $11.4M | Sell |
93,699
-4,806
| -5% | -$532K | 0.76% | 40 |
|
|
2019
Q1 | $10.2M | Sell |
98,505
-12,320
| -11% | -$1.27M | 0.69% | 47 |
|
|
2018
Q4 | $12.6M | Sell |
110,825
-6,530
| -6% | -$700K | 0.97% | 33 |
|
|
2018
Q3 | $13.5M | Sell |
117,355
-6,260
| -5% | -$686K | 0.91% | 32 |
|
|
2018
Q2 | $12.8M | Sell |
123,615
-75
| -0.1% | -$7.59K | 0.92% | 32 |
|
|
2018
Q1 | $12.2M | Sell |
123,690
-2,743
| -2% | -$259K | 0.89% | 32 |
|
|
2017
Q4 | $10.7M | Sell |
126,433
-2,475
| -2% | -$204K | 0.77% | 36 |
|
|
2017
Q3 | $9.92M | Sell |
128,908
-692
| -0.5% | -$52.9K | 0.74% | 42 |
|
|
2017
Q2 | $10.1M | Sell |
129,600
-225
| -0.2% | -$16.1K | 0.79% | 41 |
|
|
2017
Q1 | $9.34M | Sell |
129,825
-3,100
| -2% | -$214K | 0.75% | 40 |
|
|
2016
Q4 | $8.25M | Sell |
132,925
-1,000
| -0.7% | -$61.2K | 0.71% | 49 |
|
|
2016
Q3 | $8.68M | Buy |
133,925
+550
| +0.4% | +$36.6K | 0.76% | 44 |
|
|
2016
Q2 | $8.43M | Sell |
133,375
-2,100
| -2% | -$124K | 0.75% | 43 |
|
|
2016
Q1 | $7.83M | Hold |
135,475
| – | – | 0.75% | 45 |
|
|
2015
Q4 | $7.27M | Buy |
135,475
+100
| +0.1% | +$5.64K | 0.71% | 46 |
|
|
2015
Q3 | $6.9M | Buy |
135,375
+900
| +0.7% | +$48.4K | 0.72% | 43 |
|
|
2015
Q2 | $7.58M | Buy |
134,475
+1,500
| +1% | +$94.7K | 0.74% | 37 |
|
|
2015
Q1 | $9.54M | Sell |
132,975
-8,600
| -6% | -$559K | 0.93% | 23 |
|
|
2014
Q4 | $7.94M | Buy |
141,575
+100
| +0.1% | +$5.22K | 0.82% | 35 |
|
|
2014
Q3 | $6.97M | Sell |
141,475
-275
| -0.2% | -$14K | 0.76% | 38 |
|
|
2014
Q2 | $7.18M | Sell |
141,750
-2,200
| -2% | -$109K | 0.8% | 34 |
|
|
2014
Q1 | $6.43M | Buy |
143,950
+4,100
| +3% | +$184K | 0.78% | 35 |
|
|
2013
Q4 | $6.58M | Buy |
139,850
+19,250
| +16% | +$974K | 0.78% | 35 |
|
|
2013
Q3 | $6.37M | Buy |
120,600
+33,900
| +39% | +$1.64M | 0.88% | 28 |
|
|
2013
Q2 | $3.91M | Buy |
+86,700
| New | +$4.11M | 0.69% | 52 |
|
Other funds holding RMD
OCBV
Azimuth Capital Management's RMD Position: Q1 2022 in Review
Azimuth Capital Management increased its ResMed (RMD) stake by 0.21% in Q1 2022, buying an estimated $33.9K and bringing the position to 66,094 shares worth $16M. The position accounts for 0.69% of the portfolio, ranked #42.
Azimuth Capital Management first reported a position in RMD in Q2 2013 and has held it in 36 quarters since. The position peaked at $18.2M in Q3 2021. 682 funds tracked by Wall St. Rank hold RMD as of Q1 2022.
- Azimuth Capital Management held 66,094 shares of ResMed worth $16M as of Q1 2022.
- Azimuth Capital Management bought 140 ResMed shares in Q1 2022, an estimated $33.9K.
- ResMed made up 0.69% of Azimuth Capital Management's portfolio in Q1 2022, its #42 holding.
- Azimuth Capital Management first reported a position in ResMed in Q2 2013 and has held it in 36 quarters since.
- Azimuth Capital Management's ResMed position peaked at $18.2M in Q3 2021.
- 682 funds tracked by Wall St. Rank held ResMed as of Q1 2022.
Based on Azimuth Capital Management's 13F filing for Q1 2022, filed 13 May 2022.